Region: 

Board of Directors


Mara G. Aspinall

Mara G. Aspinall is president and CEO of Health Catalysts, an investment and advisory firm dedicated to the grown of new healthcare companies. Aspinall is also executive chairman of GenePeeks, a computational genomics company, and is a member of the Board of Directors of Safeguard Scientifics, Abcam plc, Castle Biosciences and Blue Cross Blue Shield Arizona. Prior to joining Health Catalysts, Aspinall was president and CEO of Ventana Medical Systems division of Roche, a worldwide leader in development and commercialization of tissue-based cancer diagnostics. She previously spent 12 years as president of Genzyme Genetics and Genzyme Pharmaceuticals. In addition to running commercial enterprises, Aspinall co-founded the International School of Biomedical Diagnostics at Arizona State University, the first school dedicated entirely to Diagnostics as an independent discipline.

Back To Top


Paul M. Black

Paul Black currently serves as board member and chief executive officer of Allscripts. As CEO, Paul guides company direction to fulfill its global commitment to build Open, connected communities of health.

Prior to joining Allscripts in 2012, Paul spent more than 13 years with Cerner Corporation in various executive positions, retiring as Cerner’s chief operating officer in 2007. During his tenure with Cerner, he helped build the company into a market leader in healthcare information technology with more than $1.5 billion in annual revenue. Paul also spent 12 years with IBM Corporation in a variety of leadership positions in sales, product marketing and professional services.

Paul has served on several private company and nonprofit boards of directors for companies in healthcare information technology, healthcare services and consumer Internet marketing. He is currently immediate past chairman and an officer of Truman Medical Centers, a 400-bed safety net academic hospital in Kansas City, Mo. Paul holds a Bachelor of Science degree from Iowa State University and a Master of Business Administration from the University of Iowa.

Back To Top


Greg Garrison

Gregory Garrison was a senior leader of PricewaterhouseCoopers for more than twenty years, most recently serving as its vice chairman and chief operating officer. He has experience in strategic planning, operations, finance, information technology, mergers and acquisitions, human capital, and sales and marketing. Over the course of his career, he has also spent considerable time meeting and working with various regulators as well as advising numerous boards and audit committees. Among other qualifications, Greg brings experience as a successful business and operations leader, professional advisor and recognized financial expert.

Back To Top


Jonathan Judge

Jonathan J. Judge currently serves on the board of directors of FEXCO Holdings Ltd., a global provider of finance and business solutions, headquartered in Ireland. From 2004 to early 2016, he served on the board of directors of PMC-Sierra, Inc., and held positions as chairman of the board and chairman of the compensation committee. From August 2010 until his retirement in January 2013, Jonathan served as the chief executive officer of First Data Corporation, a global leader in electronic commerce and payment processing. Prior to that, he served as the president and chief executive officer of Paychex Inc., a provider of payroll and human services. He also served as president and chief executive officer of Crystal Decisions, Inc. from 2002 until its merger with Business Objects S.A. in December 2003. Previously, he was employed by IBM Corporation, where he held senior management positions, most recently as general manager of its personal computing division. Among other qualifications, he brings 45 years of experience in the technology industry and extensive management, leadership and global operations expertise.

Back To Top


Michael Klayko, Chairman

Michael A. Klayko has served as chairman of the board since March 2014. He currently serves as the chief executive officer of MKA Capital, an investment company focused on technology investments. Previously, he was chief executive officer of AOptix Technologies, Inc., a privately-held provider of wireless communications and mobile network solutions, and chief executive officer of Brocade Communications Systems, Inc., a comprehensive network solutions provider. He has held executive positions, including CEO, at Rhapsody Networks, Inc., McDATA Corp., EMC Corporation, Hewlett-Packard Company and IBM Corporation. Within the past five years, Michael has served as a director of Bally Technologies, Inc., a publicly-traded manufacturer of slot machines and other gaming technologies; PMC-Sierra, Inc., a publicly-traded semiconductor company; and several other private companies in the technology industry. Among other qualifications, he brings more than 35 years of leadership experience in the technology industry as well as extensive experience in the management of worldwide operations, sales and support.

Back To Top


Yancey Spruill

Yancey L. Spruill is the chief operating officer and chief financial officer of SendGrid, Inc., a provider of email marketing services. Previously, he served as the chief financial officer of TwentyEighty, Inc., a provider of training and performance improvement solutions, and chief financial officer of DigitalGlobe, Inc., a publicly-traded provider of geospatial information products and services. He also served as a principal in the investment banking group at Thomas Weisel Partners and held roles at Lehman Brothers, Inc. and J.P. Morgan & Company as well as several manufacturing engineering roles with Corning Incorporated and The Clorox Company. Over the past five years, Yancey has served as director of Rally Software, a provider of enterprise-class software and services solutions to drive business agility, and he currently serves as a member of the Tuck School of Business MBA Advisory Board. Among other qualifications, he brings extensive financial and operating expertise, leadership experience, experience with serving on boards of directors and significant experience in the technology industry.

Back To Top


Dave Stevens

Dave B. Stevens is the founder and managing director of Keelan Capital LLC and serves as an advisor to a variety of venture capital and private equity firms and enterprises in the technology industry. He served for three years as a director of Imation Corp., a provider of global scalable storage and data security solutions. Dave was also the chief technology officer of Brocade Communications Systems, Inc., a provider of networking solutions for data centers, enterprises and service providers, having re-joined the company through its acquisition of Rhapsody Networks, for which he was the founding chief executive officer and vice president of business development. Previously, he was co-founder and chief executive officer of Palo Alto Networks, Inc., a leader in the development of cybersecurity and next-generation firewall products. He also served as the chief technology officer of transport systems for Brocade Communications Systems, Inc., and in senior management positions at Atmosphere Networks, Nortel, Bay Networks and SynOptics Communications. Among other qualifications, he brings extensive technology experience in the security, computer and data storage industries.

Back To Top


David Stevens

David D. Stevens currently serves as a private advisor and investor in private equity in the healthcare services industry. From 1983 - 2006, he served in various executive roles at Accredo Health Group, Inc. (formerly known as Accredo Health 7, Inc.) and its predecessor companies, serving as its chief executive officer, chairman of the board, president and chief operating officer. David currently serves as a director of Wright Medical Group, Inc., a publicly-traded orthopedic company that designs, manufactures and distributes extremity and biologic solutions, and several privately-held healthcare companies. During the past five years, he has served as a director of Medco Health Solutions, Inc., a pharmacy benefits management company that was publicly traded prior to its acquisition by Express Scripts, Inc. in 2012; Thomas & Betts Corporation, a manufacturer of electrical, electronic, mechanical and utility products that was publicly traded prior to its acquisition by ABB Ltd in 2012; and Viasystems Group, Inc., a leading manufacturer of complex multilayer printed circuit boards and electro-mechanical solutions that was publicly traded prior to its acquisition by TTM Technologies, Inc. in 2015. Among other qualifications, he brings extensive financial and operating expertise, leadership experience, experience with serving on boards of directors and significant experience in the healthcare industry.

Back To Top


Randy Thurman

Ralph H. “Randy” Thurman currently serves as a senior advisor in the private equity industry and executive chairman of Presbia PLC, an Orchard Capital Corporation and publicly-traded medical device company. He is a member of the executive investment council of Levitt Equity Partners, a private equity firm. In 2015, he became senior advisor at BC Partners, a private equity firm specializing in buyouts and acquisition financing. From 2008 to 2011, Randy served as executive chairman of CardioNet Inc. (now known as BioTelemetry, Inc.) and as its interim chief executive officer. Prior to that, he was founder, chairman and chief executive officer of VIASYS Healthcare Inc., a diversified healthcare technology company, which was acquired by Cardinal Healthcare Inc. in 2007. Randy served as a consultant to Cardinal Healthcare Inc. from its date of acquisition until 2008. For four years, he also served as chairman and chief executive officer of Strategic Reserves LLC, which provided advisory services to bio-pharmaceutical, genomic and medical device companies. Previously, he was chairman and chief executive officer of Corning Life Sciences, Inc. and held various positions at Rhone-Poulenc Rorer Pharmaceuticals, Inc., a global pharmaceutical company, ultimately serving as its president. Among other qualifications, he brings significant corporate governance, operating and investing expertise as well as extensive expertise in the healthcare industry.

Back To Top


What can we do for you?